ICx Technologies Reports Third-Quarter 2009 Results

* Reuters is not responsible for the content in this press release.

Thu Nov 12, 2009 4:13pm EST

http://www.businesswire.com/news/home/20091112006177/en

Records Fifth Consecutive Profitable Quarter
ARLINGTON, Va.--(Business Wire)--
ICx Technologies, Inc. (Nasdaq GS:ICXT), a developer of advanced sensor
technologies for homeland security, force protection and commercial
applications, announced today its operating and financial results for the third
quarter ended September 30, 2009. 

Third-Quarter and Nine Month Financials

For the quarter ended September 30, 2009, ICx reported revenues of $42.8
million, compared to $44.3 million for the quarter ended September 30, 2008,
representing a 3.4 percent decrease year-over-year. The Company achieved its
fifth consecutive positive quarter, showing adjusted EBITDA profits of $2.3
million, an improvement of $1.3 million over the third-quarter adjusted EBITDA
profits in 2008. Funded backlog held strong at $78 million at the end of the
third-quarter, up from $73 million reported in the second quarter. For the nine
months ended September 30, 2009, the Company`s revenue grew by 15 percent to
$135 million, compared to $117 million for the nine months ended September 30,
2008. Adjusted EBITDA for the first nine months of 2009 was $6 million compared
to an adjusted EBITDA loss of ($9.2) million for the same period last year. 

With continued positive adjusted EBITDA over five quarters, the Company has good
growth year-to-date and solid potential for the fourth-quarter despite lower
than expected revenue for the third-quarter. 

"Although contracting delays and revenue recognition delays resulted in
third-quarter revenues that were lower than expected, we are pleased with our
year to date growth," said Colin Cumming, CEO of ICx Technologies. "With our
fifth consecutive positive adjusted EBITDA quarter, we are confident in our long
term growth strategy in a difficult economic climate." 

Key Third-Quarter Highlights

* Awarded a key Detect-to-Protect Contract for Mass Transit Security

* A pilot program to rapidly detect and identify the potential release of
bio-threat agents

* The Joint Force Protection Advanced Security System (JFPASS) program achieved
a significant milestone with positive tests during the recent test and
evaluation at a major US military installation 
* Awarded a $3.6 million Mass Spectrometer Contract for the Pentagon Force
Protection Agency (PFPA)

* A key deployment for our ThreatSense facility protection technologies

* ICx Helped Secure Water Quality During the G-20 Summit in Pittsburgh, PA

* A DHS designated National Special Security Event

Revenue and Earnings Outlook for 2009

The Company is reconfirming its earlier annual Adjusted EBITDA guidance of $5
million to $8 million. Based on the delay in the DoD budget process, as well as
possible delays in certain international sales and discontinued operations, the
Company is revising its annual revenue guidance for the year ending December 31,
2009, to a range of $180 million to $190 million. 

Conference Call

In connection with the earnings release, ICx will host a conference call and
Webcast for investors and analysts to discuss its results for the quarter on
November 12, 2009, at 4:30 Eastern time. 

Participants should call, toll-free, 1.888.205.6458 (United States/Canada), or
1.913.312.1408, and request the ICx Technologies call. A telephonic replay will
be available for anyone unable to participate in the live call. To access the
replay, call 1.719.457.0820 (United States/Canada), or call toll-free at
1.888.203.1112 and enter confirmation code 9199542. The recording will be
available from 7:30 p.m. (EST) on Thursday, Nov. 12, 2009, through midnight,
Nov. 26, 2009 (EST). A live broadcast of the earnings conference call will also
be available via the Internet at http://www.ICXT.com in the 'Events &
Presentations' section under 'Investor Relations'. The webcast will be archived
on the site for 60 days. 

About ICx Technologies, Inc.

ICx Technologies is a leader in the development and integration of advanced
sensor technologies for homeland security, force protection and commercial
applications. Our proprietary sensors detect and identify chemical, biological,
radiological, nuclear and explosive threats, and deliver superior awareness and
actionable intelligence for wide-area surveillance, intrusion detection and
facility security. We then leverage our unparalleled technical expertise and
government funding to address other emerging challenges of our time, ranging
from a cleaner environment and alternative energy to life science. 

Safe-Harbor Statement

All forward-looking statements contained in this release are made within the
meaning of and pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are all statements
other than statements of historical facts, including but not limited to
statements concerning the outlook for the Company's revenues and Adjusted EBITDA
for fiscal 2009; and all other statements concerning the plans, intentions,
expectations, projections, hopes, beliefs, objectives, goals and strategies of
management. Forward-looking statements are not guarantees of future performance
or events and are subject to a number of known and unknown risks, uncertainties
and other factors that could cause actual results to differ materially from
those expressed, projected or implied by such forward-looking statements.
Important risks, uncertainties and other factors include, but are not limited
to, demand for the Company's products and services; the ability of the Company
to successfully develop and expand its products, services, technologies and
markets; the ability of the Company to effectively assimilate acquired
businesses and achieve the anticipated benefits of its acquisitions; changes in
U.S. government funding levels to purchase the Company`s products and services;
the ability of the Company to sell its products to original equipment
manufacturers, prime contractors and system integrators; seasonality;
competition; the ability of the Company to develop innovative products; the
ability of the Company to attract, retain and motivate key personnel; the
ability of the Company to secure and maintain key contracts and relationships,
including contracts with the U.S. government; general economic, market and
business conditions, uncertainties and other factors identified from time to
time in the Company's filings with the Securities and Exchange Commission.
Accordingly, there can be no assurance that the results expressed, projected or
implied by any forward-looking statements will be achieved, and readers are
cautioned not to place undue reliance on any forward-looking statements. The
forward-looking statements in this press release speak only as of the date
hereof and are based on the current plans, goals, objectives, strategies,
intentions, expectations and assumptions of, and the information currently
available to, management. The Company assumes no duty or obligation to update or
revise any forward-looking statements for any reason, whether as the result of
changes in expectations, new information, future events, conditions or
circumstances or otherwise. 

Use of Non-GAAP Financial Measures

In evaluating its business, ICx considers and uses Adjusted EBITDA as a
supplemental measure of its operating performance. The Company defines Adjusted
EBITDA as earnings from continuing operations before interest, taxes,
depreciation and amortization, plus non-cash equity compensation. The Company
also presents Adjusted EBITDA because it believes it is frequently used by
securities analysts, investors and other interested parties as a measure of
financial performance. The term Adjusted EBITDA is not defined under U.S.
generally accepted accounting principles, or U.S. GAAP, and is not a measure of
operating income, operating performance or liquidity presented in accordance
with U.S. GAAP. Adjusted EBITDA has limitations as an analytical tool, and when
assessing the Company`s operating performance, investors should not consider
Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other
consolidated income statement data prepared in accordance with U.S. GAAP. Among
other things, Adjusted EBITDA does not reflect the Company`s actual cash
expenditures. Other companies may calculate similar measures differently than
ICx, limiting their usefulness as comparative tools. ICx compensates for these
limitations by relying primarily on its GAAP results and using Adjusted EBITDA
only supplementally.

                                                                                                                                                               
 ICx TECHNOLOGIES, INC. AND SUBSIDIARIES                                                                                                                         
 Consolidated Statements of Operations and Net Loss                                                                                                              
 (Unaudited)                                                                                                                                                     
 (dollars in thousands, except per share amounts)                                                                                                                
                                                                                                                                                            
                                                           Unaudited                                            Unaudited                                  
                                                           Three Months Ended September 30,                     Nine Months Ended September 30,            
                                                           2009                             2008             2009                          2008      
 Revenues:                                                                                                                                           
 Product revenues                                       $  19,966                $          24,982        $  58,410              $         68,546    
 Contract research and development revenues                15,066                           8,854            39,041                        30,652    
 Service and other revenue                                 7,788                            10,502           37,750                        18,305    
 Total revenues                                            42,820                           44,338           135,201                       117,503   
                                                                                                                                                     
 Cost of revenues:                                                                                                                                   
 Cost of product revenues                                  9,047                            11,756           27,984                        32,842    
 Cost of contract research and development revenues        10,445                           5,909            28,325                        20,398    
 Cost of service and other revenues                        5,758                            6,919            27,289                        11,771    
 Total cost of revenue                                     25,250                           24,584           83,598                        65,011    
 Gross profit                                              17,570                           19,754           51,603                        52,492    
                                                                                                                                                     
 Operating expenses:                                                                                                                                 
 General and administrative                                6,450                            7,585            20,357                        24,938    
 Sales and marketing                                       5,354                            7,135            17,549                        23,083    
 Research and development                                  4,203                            5,494            10,823                        17,865    
 Depreciation and amortization                             2,664                            3,461            8,683                         9,822     
 Total operating expenses                                  18,671                           23,675           57,412                        75,708    
 Operating loss                                            (1,101)                          (3,921)          (5,809)                       (23,216)  
                                                                                                                                                     
 Other income (expense):                                                                                                                             
 Interest income                                           36                               191              127                           867       
 Interest expense                                          (24)                             (20)             (78)                          (49)      
 Other, net                                                (276)                            114              125                           (265)     
 Total other income (expense)                              (264)                            285              174                           553       
 Loss before income taxes                                  (1,365)                          (3,636)          (5,635)                       (22,663)  
 Income tax expense (benefit)                              (36)                             (125)            200                           75        
 Loss from continuing operations                        $  (1,329)               $          (3,511)       $  (5,835)             $         (22,738)  
 Loss on discontinued operations, net of tax               (2,528)                          (306)            (2,768)                       (1,271)   
 Loss on sale of discontinued operations, net of tax       -                                -                -                             (903)     
 Net loss                                               $  (3,857)               $          (3,817)       $  (8,603)             $         (24,912)  
                                                                                                                                                     
 Other comprehensive income                                                                                                                          
 Foreign currency translation adjustment, net of tax       797                              (1,082)          (117)                         (361)     
 Comprehensive loss                                     $  (3,060)               $          (4,899)       $  (8,720)             $         (25,273)  
                                                                                                                                                     
 Net loss per common share                                                                                                                           
 Basic and diluted                                      $  (0.11)                $          (0.11)        $  (0.25)              $         (0.73)    
                                                                                                                                                     
 Reconciliation of Non-GAAP Measure:                                                                                                                 
 Net loss                                               $  (3,857)               $          (3,817)       $  (8,603)             $         (24,912)  
 Add (subtract)                                                                                                                                      
 Loss from discontinued operations                         2,528                            306              2,768                         2,174     
 Income tax expense (benefit)                              (36)                             (125)            200                           75        
 Interest income                                           (36)                             (191)            (127)                         (867)     
 Interest expense                                          24                               20               78                            49        
 Depreciation and amortization                             2,664                            3,461            8,683                         9,822     
 Stock-based compensation expense                          979                              1,351            2,964                         4,451     
 Adjusted EBITDA                                        $  2,266                 $          1,005         $  5,963               $         (9,208)   
                                                                                                                                                     


                                                                                      
 ICx TECHNOLOGIES, INC. AND SUBSIDIARIES                                              
 Condensed Balance Sheets                                                             
 (Unaudited)                                                                          
 (dollars in thousands)                                                               
                                                                                      
                                                      September       December  
                                                      30,             31,       
 Assets                                               2009            2008      
 Current assets:                                                                
 Cash and cash equivalents                         $  22,669       $  30,354    
 Restricted cash                                      8,456           8,428     
 Trade accounts receivable, net                       31,675          36,547    
 Unbilled revenue                                     10,314          10,997    
 Inventories                                          24,007          26,174    
 Other current assets                                 5,916           2,651     
 Current assets of discontinued operations            241             619       
 Total current assets                                 103,278         115,770   
 Property, plant and equipment, net                   10,517          10,850    
 Goodwill and intangibles, net                        81,681          87,575    
 Other noncurrent assets                              3,175           2,344     
 Noncurrent assets of discontinued operations         378             2,759     
 Total assets                                      $  199,029      $  219,298   
                                                                                
 Liabilities and Stockholders' Equity                                           
                                                                                
 Current liabilities                               $  25,740       $  38,828    
 Current liabilities of discontinued operations       118             198       
 Noncurrent liabilities                               1,486           2,465     
 Total liabilities                                    27,344          41,491    
                                                                                
 Total stockholders' equity                           171,685         177,807   
 Total liabilities and stockholders' equity        $  199,029      $  219,298   
                                                                                


                                                                                                                                                                
 ICx TECHNOLOGIES, INC. AND SUBSIDIARIES                                                                                                                        
 Selected Segment Information                                                                                                                                   
 (Unaudited)                                                                                                                                                    
 (dollars in thousands)                                                                                                                                         
                                                                                                                                                         
                                              Three Months Ended                                             Nine Months Ended                              
                                              September 30,                                                  September 30,                                  
                                              2009                            2008                         2009                     2008                
 Detection                                                                                                                                              
 Product revenue                              $             10,800          $   16,716                 $    30,981            $    43,277       
 Contract research and development revenue                  14,594              8,070                       38,252                 24,143       
 Service and other revenue                                  795                 633                         2,477                  1,429        
 Total revenue                                $             26,189          $   25,419                 $    71,710            $    68,849       
 Gross profit %                                             41.5    %           51.5             %          40.7    %              49.8    %    
                                                                                                                                                      
 Surveillance                                                                                                                                         
 Product revenue                              $             7,111           $   6,523                  $    21,638            $    19,221       
 Contract research and development revenue                  472                 612                         789                    6,303        
 Service and other revenue                                  1,662               5,536                       16,287                 6,392        
 Total revenue(1)                             $             9,245           $   12,671                 $    38,714            $    31,916       
 Gross profit %                                             43.4    %           34.5             %          36.4    %              37.4    %    
                                                                                                                                                      
 Solutions                                                                                                                                            
 Product revenue                              $             2,144           $   1,743                  $    5,912             $    6,047        
 Contract research and development revenue                  63                  172                         219                    206          
 Service and other revenue                                  5,537               4,333                       19,453                 10,484       
 Total revenue(2)                             $             7,744           $   6,248                  $    25,584            $    16,737       
 Gross profit %                                             34.7    %           36.6             %          32.6    %              37.7    %    
                                                                                                                                                      


(1) Includes $64 and $72 of intersegment revenue that has been eliminated in the
Consolidated Statement of Operations and Net Loss for the three and nine months
ended September 30, 2009, respectively 

(2) Includes $294 and $735 of intersegment revenue that has been eliminated in
the Consolidated Statement of Operations and Net Loss for the three and nine
months ended September 30, 2009, respectively

ICx Technologies, Inc.
Media
Melissa Woods, + 1-405-269-9453
melissa.woods@icxt.com
or
Investor Relations
Jessica Bartlow, + 1-703-678-2114
jessica.bartlow@icxt.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.